Due to a shortage of certain commonly used blood pressure drugs, the FDA took the unusual step of reminding patients that they have access to available -- if tainted -- medicines while a fresh supply of uncontaminated pills is manufactured.
Due to a shortage of certain commonly used blood pressure drugs, the US Food and Drug Administration took the unusual step Thursday of reminding patients that they have access to available -- if tainted -- medicines while a fresh supply of uncontaminated pills is manufactured.
Since July, separate lots of angiotensin II receptor blockers or ARBs have been pulled from pharmacy shelves due to manufacturing impurities. Some of these drugs, which contain valsartan, losartan or irbesartan as the active pharmaceutical ingredient, had been tainted by nitrosamines, the FDA reported. Nitrosamines, which may be unintentionally introduced when certain chemical reactions are used in the production process, pose a cancer risk.
The FDA maintains that"even if they learn that their ARB medicine is recalled," patients should continue taking their pills until their doctor or pharmacist provides a different treatment option or safe replacement. "We'll continue to prioritize our investigation into this ongoing issue," Gottlieb and Woodcock concluded."This will remain an area of intense focus in the months ahead.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Vaping may cause seizures, especially among teens, FDA says“We have reports indicating that some people who use e-cigarettes, especially youth and young adults, are experiencing seizures following their use,” FDA commissioner says in a statement. - TODAYshow
Consulte Mais informação »
FDA sends letters to 20 companies in attempt to rein in stem cell industryThe enforcment action comes after years of scientists’ demands for agency to do more.
Consulte Mais informação »
FDA investigating possible seizure risk with e-cigarette useThe FDA said it is investigating reports of e-cigarette users experiencing seizures. There have been a small number of cases over several years.
Consulte Mais informação »
U.S. FDA warns of potential seizure risk in some users of e-cigarettesThe U.S. Food and Drug Administration on Wednesday warned of potential safety ri...
Consulte Mais informação »
FDA is investigating nearly three dozen reports of seizures after vapingBetween 2010 and 2019, the FDA received 35 reports of people having seizures after using e-cigarettes. The cause of the seizures is unclear.
Consulte Mais informação »
FDA investigates reports of seizures after vapingThe US Food and Drug Administration announced Wednesday it is investigating a possible connection between e-cigarette use and seizures in younger users.
Consulte Mais informação »
Outgoing FDA chief Gottlieb raises 'concern' over Walgreens, CVS selling CBD productsOutgoing Food and Drug Administration Commissioner Scott Gottlieb told lawmakers Wednesday that he's uneasy about Walgreens' and CVS' recent decisions to start selling CBD products in their drugstores.
Consulte Mais informação »
FDA warns that e-cigarette use may cause seizuresThe agency has received 35 reports of seizures among e-cigarettes users, mainly in teens and young adults, since 2010.
Consulte Mais informação »
Tobacco stocks drop as FDA probes possible link between seizures and vapingTobacco stocks dipped Wednesday after the FDA announced it's investigating nearly three dozen cases of people experiencing seizures after vaping.
Consulte Mais informação »